Table of Contents
ISRN Dentistry
Volume 2011 (2011), Article ID 125168, 7 pages
http://dx.doi.org/10.5402/2011/125168
Research Article

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers

1Department of Pharmacology, University of Greifswald, 17475 Greifswald, Germany
2Department of Dental Clinics, Unit of Periodontology, University of Greifswald, 17475 Greifswald, Germany
3Department of Community Medicine, University of Greifswald, 17475 Greifswald, Germany
4Department of Clinical Chemistry, University of Greifswald, 17475 Greifswald, Germany

Received 8 August 2011; Accepted 4 September 2011

Academic Editors: Y. Abe and F. Cairo

Copyright © 2011 Peter Meisel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Albandar, “Global risk factors and risk indicators for periodontal diseases,” Periodontology 2000, vol. 29, no. 1, pp. 177–206, 2002. View at Google Scholar · View at Scopus
  2. M. S. Al-Zahrani, R. A. Kayal, and N. F. Bissada, “Periodontitis and cardiovascular disease: a review of shared risk factors and new findings supporting a causality hypothesis,” Quintessence International, vol. 37, no. 1, pp. 11–18, 2006. View at Google Scholar · View at Scopus
  3. J. D. Beck and S. Offenbacher, “Relationships among clinical measures of periodontal disease and their associations with systemic markers,” Annals of Periodontology, vol. 7, no. 1, pp. 79–89, 2002. View at Google Scholar · View at Scopus
  4. A. M. Iacopino and C. W. Cutler, “Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids,” Journal of Periodontology, vol. 71, no. 8, pp. 1375–1384, 2000. View at Google Scholar · View at Scopus
  5. C. Arnaud, N. R. Veillard, and F. Mach, “Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis,” Current Drug Targets. Cardiovascular and Haematological Disorders, vol. 5, no. 2, pp. 127–134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Yoshida, “Potential role of statins in inflammation and atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 10, no. 3, pp. 140–144, 2003. View at Google Scholar · View at Scopus
  7. J. Cunha-Cruz, B. Saver, G. Maupome, and P. P. Hujoel, “Statin use and tooth loss in chronic periodontitis patients,” Journal of Periodontology, vol. 77, no. 6, pp. 1061–1066, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. G. Saver, P. P. Hujoel, J. Cunha-Cruz, and G. Maupomé, “Are statins associated with decreased tooth loss in chronic periodontitis?” Journal of Clinical Periodontology, vol. 34, no. 3, pp. 214–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Lindy, K. Suomalainen, M. Mäkelä, and S. Lindy, “Statin use is associated with fewer periodontal lesions: a retrospective study,” BMC Oral Health, vol. 8, no. 1, article no. 16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Saxlin, L. Suominen-Taipale, M. Knuuttila, P. Alha, and P. Ylöstalo, “Dual effect of statin medication on the periodontium,” Journal of Clinical Periodontology, vol. 36, no. 12, pp. 997–1003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Hensel, D. Gesch, R. Biffar et al., “Study of Health in Pomerania (SHIP): a health survey in an East German region. Objectives and design of the oral health section,” Quintessence International, vol. 34, no. 5, pp. 370–378, 2003. View at Google Scholar · View at Scopus
  12. WHO Collaborating Centre for Drug Statistics Methodology, “ATC Index,” Oslo, Norway, 2003, http://www.whocc.no/atcddd.
  13. S. Selvin, Statistical Analysis of Epidemiological Data, vol. 25 of J. L. Keley et al., Eds., Monographs in Epidemiology and Biostatics, Oxford University Press, 1996.
  14. N. Rifai and P. M. Ridker, “Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening,” Clinical Chemistry, vol. 47, no. 1, pp. 28–29, 2001. View at Google Scholar · View at Scopus
  15. U. van der Velden, “The significance of supragingival plaque accumulation in periodontal disease,” International Journal of Dental Hygiene, vol. 4, pp. 11–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. J. Mattila, P. J. Pussinen, and S. Paju, “Dental infections and cardiovascular diseases: a review,” Journal of Periodontology, vol. 76, no. 11, pp. 2085–2088, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Söder, “Dental plaque as a possible risk factor for general disease–results from longitudinal studies,” International Journal of Dental Hygiene, vol. 4, supplement 1, pp. 22–25, 2006. View at Publisher · View at Google Scholar
  18. K. J. Joshipura, H. C. Wand, A. T. Merchant, and E. B. Rimm, “Periodontal disease and biomarkers related to cardiovascular disease,” Journal of Dental Research, vol. 83, no. 2, pp. 151–155, 2004. View at Google Scholar · View at Scopus
  19. J. Katz, M. Y. Flugelman, A. Goldberg, and M. Heft, “Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels,” Journal of Periodontology, vol. 73, no. 5, pp. 494–500, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Kowolik, S. A. Dowsett, J. Rodriguez, M. De La Rosa, and G. J. Eckert, “Systemic neutrophil response resulting from dental plaque accumulation,” Journal of Periodontology, vol. 72, no. 2, pp. 146–151, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Tüter, B. Kurtiş, M. Serdar et al., “Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease,” Journal of Clinical Periodontology, vol. 34, no. 8, pp. 673–681, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Paju, J. Sinisalo, P. J. Pussinen, V. Valtonen, and M. S. Nieminen, “Is periodontal infection behind the failure of antibiotics to prevent coronary events?” Atherosclerosis, vol. 193, no. 1, pp. 193–195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Sakoda, M. Yamamoto, Y. Negishi, J. K. Liao, K. Node, and Y. Izumi, “Simvastatin decreases IL-6 and IL-8 production in epithelial cells,” Journal of Dental Research, vol. 85, no. 6, pp. 520–523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. E. S. Istvan, “Bacterial and mammalian HMG-CoA reductases: Related enzymes with distinct architectures,” Current Opinion in Structural Biology, vol. 11, no. 6, pp. 746–751, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Noack, R. J. Genco, M. Trevisan, S. Grossi, J. J. Zambon, and E. De Nardin, “Periodontal infections contribute to elevated systemic C-reactive protien level,” Journal of Periodontology, vol. 72, no. 9, pp. 1221–1227, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Nareika, A. Maldonado, L. He et al., “High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin,” Journal of Periodontal Research, vol. 42, no. 1, pp. 31–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. B. A. Taylor, G. H. Tofler, H. M. R. Carey et al., “Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk,” Journal of Dental Research, vol. 85, no. 1, pp. 74–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. F. D'Aiuto, M. Parkar, G. Andreou et al., “Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers,” Journal of Dental Research, vol. 83, no. 2, pp. 156–160, 2004. View at Google Scholar · View at Scopus
  29. M. H. Davidson, “Clinical significance of statin pleiotropic effects: hypotheses versus evidence,” Circulation, vol. 111, no. 18, pp. 2280–2281, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Ferro, S. Parrotto, S. Basili, C. Alessandri, and F. Violi, “Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia,” Journal of the American College of Cardiology, vol. 36, no. 2, pp. 427–431, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. S. E. Nissen, E. M. Tuzcu, P. Schoenhagen et al., “Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease,” New England Journal of Medicine, vol. 352, no. 1, pp. 29–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Jialal, D. Stein, D. Balis, S. M. Grundy, B. Adams-Huet, and S. Devaraj, “Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels,” Circulation, vol. 103, no. 15, pp. 1933–1935, 2001. View at Google Scholar · View at Scopus
  33. M. E. Fajardo, M. L. Rocha, F. J. Sánchez-Marin, and E. J. Espinosa-Chávez, “Effect of atorvastatin on chronic periodontitis: a randomized pilot study,” Journal of Clinical Periodontology, vol. 37, no. 11, pp. 1016–1022, 2010. View at Publisher · View at Google Scholar
  34. A. R. Pradeep and M. S. Thorat, “Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial,” Journal of Periodontology, vol. 81, no. 2, pp. 214–222, 2010. View at Publisher · View at Google Scholar · View at Scopus